TRAF3IP2 / ACT1 Antibody (N-Terminus)
LS-C135292
ApplicationsWestern Blot
Product group Antibodies
ReactivityHuman
TargetTRAF3IP2
Overview
- SupplierLifeSpan BioSciences
- Product NameTRAF3IP2 / ACT1 Antibody (N-Terminus)
- Delivery Days Customer14
- Antibody SpecificityHuman TRAF3IP2 / ACT1
- Application Supplier NoteWestern Blot: Suggested dilution at 1 ug/ml in 5% skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.
- ApplicationsWestern Blot
- Applications SupplierWB (0.2 - 1 µg/ml) Western Blot: Suggested dilution at 1 ug/ml in 5% skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5 mg/ml
- ConjugateUnconjugated
- Estimated Purity...
- Gene ID10758
- Target nameTRAF3IP2
- Target descriptionTRAF3 interacting protein 2
- Target synonymsACT1; adapter protein CIKS; C6orf2; C6orf4; C6orf5; C6orf6; CANDF8; CIKS; connection to IKK and SAPK/JNK; E3 ubiquitin ligase TRAF3IP2; E3 ubiquitin-protein ligase CIKS; NFkB-activating protein ACT1; nuclear factor NF-kappa-B activator 1; PSORS13; symbol withdrawn, see C6orf4
- HostRabbit
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203